Cost-effectiveness of colorectal cancer screening in the average risk population
- PMID: 12943152
- DOI: 10.1023/a:1024488007043
Cost-effectiveness of colorectal cancer screening in the average risk population
Abstract
Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.
Similar articles
-
Cost-effectiveness of screening for colorectal cancer in the general population.JAMA. 2000 Oct 18;284(15):1954-61. doi: 10.1001/jama.284.15.1954. JAMA. 2000. PMID: 11035892
-
Cost-effectiveness of colonoscopy in screening for colorectal cancer.Ann Intern Med. 2000 Oct 17;133(8):573-84. doi: 10.7326/0003-4819-133-8-200010170-00007. Ann Intern Med. 2000. PMID: 11033584
-
Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.Eur J Radiol. 2012 Jul;81(7):1413-9. doi: 10.1016/j.ejrad.2011.03.027. Epub 2011 Mar 27. Eur J Radiol. 2012. PMID: 21444171
-
Screening of colorectal cancer.Surg Oncol Clin N Am. 2005 Oct;14(4):699-722. doi: 10.1016/j.soc.2005.05.009. Surg Oncol Clin N Am. 2005. PMID: 16226687 Review.
-
Screening for colorectal cancer: what fits best?Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):301-12. doi: 10.1586/egh.12.12. Expert Rev Gastroenterol Hepatol. 2012. PMID: 22646253 Review.
Cited by
-
Cost-Effectiveness Evaluation of EHR: Simulation of an Abdominal Aortic Aneurysm in the Emergency Department.J Med Syst. 2016 Jun;40(6):141. doi: 10.1007/s10916-016-0502-9. Epub 2016 Apr 25. J Med Syst. 2016. PMID: 27114352
-
Probability model for estimating colorectal polyp progression rates.Health Care Manag Sci. 2011 Mar;14(1):1-21. doi: 10.1007/s10729-010-9138-3. Epub 2010 Oct 5. Health Care Manag Sci. 2011. PMID: 20922484
-
Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.BMC Cancer. 2015 Oct 15;15:705. doi: 10.1186/s12885-015-1730-y. BMC Cancer. 2015. PMID: 26471036 Free PMC article. Clinical Trial.
-
Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.Cost Eff Resour Alloc. 2010 Mar 17;8:2. doi: 10.1186/1478-7547-8-2. Cost Eff Resour Alloc. 2010. PMID: 20236531 Free PMC article.
-
Using Sequential Decision Making to Improve Lung Cancer Screening Performance.IEEE Access. 2019;7:119403-119419. doi: 10.1109/ACCESS.2019.2935763. Epub 2019 Aug 16. IEEE Access. 2019. PMID: 32754420 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical